Kvale D, Rognum T O, Thorud E, Fosså S D, Rø J S, Brandtzaeg P
J Clin Pathol. 1987 Jun;40(6):621-5. doi: 10.1136/jcp.40.6.621.
The serum concentrations of IgAp and IgMr associated secretory component (SIgA and SIgM) of 98 patients with neoplasms of the breast were measured. Of the 56 patients with carcinomas, 11 had increased concentrations of circulating SIgM, which was almost twice as sensitive as SIgA as a marker for carcinoma. Concentrations of circulating SIgA and SIgM were independent of expression of secretory component, IgA, and carcinoembryonic antigen (CEA); histological tumour grade; and tumour cell DNA ploidy, whereas a weak correlation between SIgA and SIgM and circulating CEA was seen. The three patients who had liver metastases indicated had particularly high concentrations of circulating SIgA and SIgM, whereas no difference was generally seen between patients with malignancy and those with benign tumours.
对98例乳腺癌患者的血清中与分泌成分相关的IgAp和IgMr(分泌型IgA和分泌型IgM)浓度进行了测定。在56例癌症患者中,11例循环分泌型IgM浓度升高,作为癌症标志物,其敏感性几乎是分泌型IgA的两倍。循环分泌型IgA和分泌型IgM的浓度与分泌成分、IgA和癌胚抗原(CEA)的表达;组织学肿瘤分级;以及肿瘤细胞DNA倍体无关,而分泌型IgA和分泌型IgM与循环CEA之间存在弱相关性。有肝转移指征的3例患者循环分泌型IgA和分泌型IgM浓度特别高,而恶性肿瘤患者和良性肿瘤患者之间一般无差异。